Deborah Ann Rathien

Title: The Innovations of Deborah Ann Rathien

Introduction

Deborah Ann Rathien is a notable inventor based in Thornleigh, Australia. She has made significant contributions to the field of biotechnology, particularly in the development of peptides that stimulate neutrophil function. Her work has implications for treating conditions associated with depressed neutrophil activity.

Latest Patents

Deborah holds a patent for "Neutrophil stimulating peptides." This invention provides peptides capable of stimulating neutrophils, which are essential components of the immune system. The peptides are designed to prime neutrophils for a respiratory burst following treatment with N-formyl-L-methionyl-L-leucyl-L-phenylalanine. The amino acid sequence of these peptides corresponds substantially to amino acids 54 to 94 of a specified figure, or parts thereof. This innovation may also be utilized in treating subjects with impaired neutrophil function.

Career Highlights

Deborah has established herself as a key figure in her field through her innovative research and development efforts. Her work at Peptide Technology Limited has allowed her to explore the therapeutic potential of peptides in various medical applications.

Collaborations

Deborah collaborates with Antonio Ferrante, contributing to advancements in peptide technology and its applications in medicine.

Conclusion

Deborah Ann Rathien's contributions to the field of biotechnology through her innovative patents highlight her role as a leading inventor in peptide research. Her work continues to pave the way for new treatments that enhance immune function.